ROCHESTER, Minn. — Did you know multiple sclerosis (MS) means multiple scars? New research shows that the brain and spinal cord scars in people with[...]
The Food and Drug Administration (FDA) approved aducanumab to treat Alzheimer's disease on Monday, June 7. About 6 million people in the U.S. and 30[...]
ROCHESTER, Minn. — Two proteins that can be measured in the blood — plasma total tau and neurofilament light — are associated with brain cell[...]
Mayo Clinic lights buildings for World Encephalitis Day ROCHESTER, Minn. ― Patients with COVID-19 are at risk for neurologic complications, including encephalitis, or inflammation of[...]
In February, a team of five health care staff members donned personal protective equipment and prepared to care for a Mayo Clinic patient considered to[...]
ROCHESTER, Minn. — Misplacing keys, forgetting the way to a doctor's appointment, trouble recalling a neighbor’s name: Are these examples of typical aging? What’s the[...]
The COVID-19 pandemic has caused much stress and uncertainty for students, parents, teachers and staff. "For students and the adults who care for them, the[...]
Families and school districts are weighing difficult decisions on whether to return to school in person, online or a combination of both during the COVID-19[...]
ROCHESTER, Minn. — People with conditions such as spinal cord injury, Lou Gehrig's disease and multiple sclerosis are at risk of developing severe respiratory problems[...]
ROCHESTER, Minn. — The toxic protein tau is a key biological feature in the brains of people with Alzheimer's disease. Yet the factors that make[...]
ROCHESTER, Minn. — The National Institutes of Health has awarded a five-year, multi-investigator research grant expected to total more than $63 million to Mayo Clinic[...]